Elucid vs Subtle Medical

Subtle Medical's software works on how images are acquired and reconstructed, and the vendor claims MRI sequences up to 80% faster and PET scans up to 75% faster. SubtleHD-CT, cleared in May 2026, reduces noise and improves low-contrast detectability. AiMIFY, built with Bracco and cleared in August 2024, is the vendor's route to contrast-enhanced brain MRI at a lower gadolinium dose. Subtle publishes no price. Elucid's pipeline has its own image restoration step that reduces motion and calcium blooming, after which trained analysts segment a 3D model of the coronary arteries, and the provider is billed per analysis. An MR and PET department with a scheduling backlog, or a neuroradiology service trying to cut gadolinium dose, buys Subtle. A coronary CT program that wants plaque numbers in the report buys Elucid.